Overview
A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography
Status:
Completed
Completed
Trial end date:
2006-06-01
2006-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The main purpose of this study is to compare the incidence of contrast induced nephrotoxicity following the administration of Isovue or Visipaque in patients with moderate to severe renal insufficiency undergoing cardiac angiography. Serum creatinine will be measured before and up to 48-72 hours after the administration of the contrast agent to evaluate renal function.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bracco Diagnostics, Inc
Criteria
Inclusion Criteria:- Referred for cardiac angiography; with a documented predose eGFR of greater than or
equal to 20 and less than 60 mL/min/1.73m2
Exclusion Criteria:
- Unstable renal function; concurrent administration of nephrotoxic drugs, undergoing
dialysis